PER 1.22% 8.1¢ percheron therapeutics limited

Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-84

  1. 4,316 Posts.
    lightbulb Created with Sketch. 2019
    The trial runs for 12 months. Dosing lasts 6 months. Futility will happen when the last patient completes their 6 month dose schedule. That is planned to occur 12 months after the 1st arm is dosed. The extension trial continues after Futility.

    Have a look at the timeline from around CR time. They had a good diagram thst showed what was happening.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.001(1.22%)
Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.